ストックスクリーナーアプリを入手
5.05
1.94%
-0.10
前日終値:
$5.15
開ける：
$5.04
24時間の取引高:
51,017
Relative Volume:
0.16
時価総額：
$8.00M
収益：
-
当期純損益:
$-14.58M
株価収益率:
-4.3913
EPS:
-1.15
ネットキャッシュフロー:
$-9.80M
1週間 パフォーマンス:
+13.87%
1か月 パフォーマンス:
-43.89%
6か月 パフォーマンス:
-64.44%
1年 パフォーマンス:
-88.09%
1日の値動き範囲:
$4.95
$5.285
1週間の範囲:
$4.5101
$5.3679
52週間の値動き範囲:
$3.80
$47.80
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
名前
Acurx Pharmaceuticals Inc
セクター
電話
917-533-1469
住所
259 LIBERTY AVENUE, STATEN ISLAND
ACXP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
5.05 | 7.86M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.76 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.28 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.78 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
656.89 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
312.51 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc (ACXP) 最新ニュース
Technical analysis overview for Acurx Pharmaceuticals Inc. stockSell Signal & Verified Short-Term Trading Plans - Newser
Published on: 2025-08-20 00:25:12 - Newser
Will Acurx Pharmaceuticals Inc. benefit from macro trendsStop Loss & Weekly Top Gainers Trade List - Newser
Acurx Pharmaceuticals Inc. stock momentum explained2025 Macro Impact & Daily Entry Point Trade Alerts - Newser
What does recent volatility data suggest for Acurx Pharmaceuticals Inc.Earnings Recap Summary & Growth Focused Investment Plans - Newser
Statistical indicators supporting Acurx Pharmaceuticals Inc.’s strength2025 Market Overview & Daily Price Action Insights - Newser
What technical models suggest about Acurx Pharmaceuticals Inc.’s comebackJuly 2025 Action & Free Growth Oriented Trading Recommendations - Newser
What’s the recovery path for long term holders of Acurx Pharmaceuticals Inc.Portfolio Risk Summary & Entry and Exit Point Strategies - Newser
Will a bounce in Acurx Pharmaceuticals Inc. offer an exitWeekly Gains Report & Community Trade Idea Sharing - Newser
Can volume confirm reversal in Acurx Pharmaceuticals Inc.Trend Reversal & High Accuracy Buy Signal Tips - Newser
Key metrics from Acurx Pharmaceuticals Inc.’s quarterly dataJuly 2025 Weekly Recap & Fast Momentum Entry Tips - Newser
Signal strength of Acurx Pharmaceuticals Inc. stock in tech scannersJuly 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - Newser
How high can Acurx Pharmaceuticals Inc. stock goJuly 2025 Decliners & Breakout Confirmation Alerts - Newser
Real time pattern detection on Acurx Pharmaceuticals Inc. stockMarket Movers & AI Powered Trade Plan Recommendations - Newser
Why Acurx Pharmaceuticals Inc. stock attracts strong analyst attention2025 Major Catalysts & Free Growth Oriented Trading Recommendations - Newser
Published on: 2025-08-19 06:44:47 - Newser
Strategies to average down on Acurx Pharmaceuticals Inc.2025 Market Outlook & Daily Stock Trend Watchlist - Newser
Will Acurx Pharmaceuticals Inc. continue its uptrendGlobal Markets & Real-Time Buy Zone Alerts - Newser
Published on: 2025-08-19 00:32:30 - Newser
Chart based exit strategy for Acurx Pharmaceuticals Inc.Trade Ideas & Intraday High Probability Setup Alerts - Newser
Can Acurx Pharmaceuticals Inc. rally from current levelsJuly 2025 Gainers & Weekly Sector Rotation Insights - Newser
Acurx Pharmaceuticals (NASDAQ:ACXP) Upgraded by Wall Street Zen to Hold Rating - Defense World
Multi asset correlation models including Acurx Pharmaceuticals Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - Newser
Does Acurx Pharmaceuticals Inc. fit your quant trading modelQuarterly Market Summary & Reliable Price Action Trade Plans - Newser
Acurx signals ongoing cost controls and new trial funding avenues while advancing ibezapolstat clinical program - MSN
Tools to assess Acurx Pharmaceuticals Inc.’s risk profile2025 EndofYear Setup & Precise Swing Trade Alerts - Newser
Published on: 2025-08-16 01:02:27 - Newser
Intraday pattern recognizer results for Acurx Pharmaceuticals Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - Newser
Acurx Pharmaceuticals Inc (ACXP) 財務データ
収益
当期純利益
現金流量
EPS
Acurx Pharmaceuticals Inc (ACXP) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Sailer Carl | Director |
Jan 06 '25 |
Buy |
1.01 |
24,631 |
25,000 |
137,183 |
| LUCI DAVID P | President and CEO |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,097,458 |
| Donohue James J. | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
22,352 |
| DELUCCIA ROBERT J | Director |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,010,196 |
| DEAN JACK H | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
21,776 |
0.22%
3.58%
大文字化:
|
ボリューム (24 時間):